These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms. Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer. Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909 [TBL] [Abstract][Full Text] [Related]
7. Cloning of tissue-specific genes using serial analysis of gene expression and a novel computational substraction approach. Moreno JC; Pauws E; van Kampen AH; Jedlicková M; de Vijlder JJ; Ris-Stalpers C Genomics; 2001 Jul; 75(1-3):70-6. PubMed ID: 11472069 [TBL] [Abstract][Full Text] [Related]
8. Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information. Montero-Conde C; Martín-Campos JM; Lerma E; Gimenez G; Martínez-Guitarte JL; Combalía N; Montaner D; Matías-Guiu X; Dopazo J; de Leiva A; Robledo M; Mauricio D Oncogene; 2008 Mar; 27(11):1554-61. PubMed ID: 17873908 [TBL] [Abstract][Full Text] [Related]
9. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas. Soda G; Antonaci A; Bosco D; Nardoni S; Melis M J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma. Rossing M; Borup R; Henao R; Winther O; Vikesaa J; Niazi O; Godballe C; Krogdahl A; Glud M; Hjort-Sørensen C; Kiss K; Bennedbæk FN; Nielsen FC J Mol Endocrinol; 2012 Feb; 48(1):11-23. PubMed ID: 22049245 [TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays. Zhao J; Leonard C; Brunner E; Gemsenjäger E; Heitz PU; Odermatt B Int J Oncol; 2006 Nov; 29(5):1041-51. PubMed ID: 17016634 [TBL] [Abstract][Full Text] [Related]
12. Classification of follicular thyroid tumors by molecular signature: results of gene profiling. Barden CB; Shister KW; Zhu B; Guiter G; Greenblatt DY; Zeiger MA; Fahey TJ Clin Cancer Res; 2003 May; 9(5):1792-800. PubMed ID: 12738736 [TBL] [Abstract][Full Text] [Related]
13. Differential expression of IGFBP-5 and two human ESTs in thyroid glands with goiter, adenoma and papillary or follicular carcinomas. Stolf BS; Carvalho AF; Martins WK; Runza FB; Brun M; Hirata R; Jordão Neves E; Soares FA; Postigo-Dias J; Kowalski LP; Reis LF Cancer Lett; 2003 Mar; 191(2):193-202. PubMed ID: 12618333 [TBL] [Abstract][Full Text] [Related]
14. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy. Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498 [TBL] [Abstract][Full Text] [Related]
15. Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness. Ulivieri A; Lavra L; Dominici R; Giacomelli L; Brunetti E; Sciacca L; Trovato M; Barresi G; Foukakis T; Jia-Jing L; Larsson C; Bartolazzi A; Sciacchitano S J Pathol; 2008 May; 215(1):87-96. PubMed ID: 18306168 [TBL] [Abstract][Full Text] [Related]
16. The expression and role of serum response factor in papillary carcinoma of the thyroid. Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551 [TBL] [Abstract][Full Text] [Related]